{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T12:55:54Z","timestamp":1793451354631,"version":"4.5.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014054","name":"Drugs for Neglected Diseases initiative","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014054","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Semin Immunopathol"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Progress has been made in the control or elimination of tropical diseases, with a significant reduction of incidence. However, there is a risk of re-emergence if the factors fueling transmission are not dealt with. Although it is essential to understand these underlying factors for each disease, asymptomatic carriers are a common element that may promote resurgence; their impact in terms of proportion in the population and role in transmission needs to be determined. In this paper, we review the current evidence on whether or not to treat asymptomatic carriers given the relevance of their role in the transmission of a specific disease, the efficacy and toxicity of existing drugs, the Public Health interest, and the benefit at an individual level, for example, in Chagas disease, to prevent irreversible organ damage. In the absence of other control tools such as vaccines, there is a need for safer drugs with good risk\/benefit profiles in order to change the paradigm so that it addresses the complete infectious process beyond manifest disease to include treatment of non-symptomatic infected persons.<\/jats:p>","DOI":"10.1007\/s00281-020-00796-y","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T13:55:40Z","timestamp":1584539740000},"page":"231-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases"],"prefix":"10.1007","volume":"42","author":[{"given":"Jorge","family":"Alvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bucheton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Burrows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"B\u00fcscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Felger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jesus","family":"Pinazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Sosa-Estani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tarral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Strub","family":"Wourgaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Bilbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"796_CR1","unstructured":"Mansfield J, Olivier M (2011) Immune evasion by parasites. In: Kaufmann S, Rouse B, Sacks D (eds) The immune response to infection. ASM Press Washington DC"},{"key":"796_CR2","doi-asserted-by":"crossref","unstructured":"Lamb TJ (2012) Immunity to parasitic infection, 1st edn. Wiley-Blackwell","DOI":"10.1002\/9781118393321"},{"key":"796_CR3","unstructured":"World Health Organization (2015) Chagas disease in Latin America: an epidemiological update based on 2010 estimates. Wkly Epidemiol Rec:33\u201344"},{"key":"796_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S1473-3099(01)00065-2","volume":"1","author":"A Prata","year":"2001","unstructured":"Prata A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1:92\u2013100. https:\/\/doi.org\/10.1016\/S1473-3099(01)00065-2","journal-title":"Lancet Infect Dis"},{"key":"796_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.exppara.2004.07.001","volume":"108","author":"D Villarreal","year":"2004","unstructured":"Villarreal D, Barnab\u00e9 C, Sereno D, Tibayrenc M (2004) Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease. Exp Parasitol 108:24\u201331. https:\/\/doi.org\/10.1016\/j.exppara.2004.07.001","journal-title":"Exp Parasitol"},{"key":"796_CR6","doi-asserted-by":"publisher","first-page":"e0137788","DOI":"10.1371\/journal.pone.0137788","volume":"10","author":"NC Nogueira-Paiva","year":"2015","unstructured":"Nogueira-Paiva NC, De AbreuVieira PM, Oliveri LMR et al (2015) Host-parasite interactions in Chagas disease: genetically unidentical isolates of a single Trypanosoma cruzi strain identified in vitro via LSSP-PCR. PLoS One 10:e0137788. https:\/\/doi.org\/10.1371\/journal.pone.0137788","journal-title":"PLoS One"},{"key":"796_CR7","doi-asserted-by":"publisher","unstructured":"S\u00e1nchez-Vald\u00e9z FJ, Padilla A, Wang W et al (2018) Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure. Elife:e34039. https:\/\/doi.org\/10.7554\/eLife.34039","DOI":"10.7554\/eLife.34039"},{"key":"796_CR8","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/CIRCULATIONAHA.106.624296","volume":"115","author":"JA Marin-Neto","year":"2007","unstructured":"Marin-Neto JA, Cunha-Neto E, Maciel BC, Sim\u00f5es MV (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115:1109\u20131123. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.624296","journal-title":"Circulation"},{"key":"796_CR9","doi-asserted-by":"publisher","first-page":"e3312","DOI":"10.1371\/journal.pntd.0003312","volume":"8","author":"DL Fabbro","year":"2014","unstructured":"Fabbro DL, Danesi E, Olivera V, Codeb\u00f3 MO, Denner S, Heredia C, Streiger M, Sosa-Estani S (2014) Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas. PLoS Negl Trop Dis 8:e3312. https:\/\/doi.org\/10.1371\/journal.pntd.0003312","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR10","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1001\/jama.298.18.2171","volume":"298","author":"C Bern","year":"2007","unstructured":"Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, Gilman RH, Reyes PA, Salvatella R, Moore AC (2007) Evaluation and treatment of Chagas disease in the United States: a systematic review. J Am Med Assoc 298:2171\u20132181. https:\/\/doi.org\/10.1001\/jama.298.18.2171","journal-title":"J Am Med Assoc"},{"key":"796_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","volume":"18","author":"F Torrico","year":"2018","unstructured":"Torrico F, Gascon J, Ortiz L, Alonso-Vega C, Pinazo MJ, Schijman A, Almeida IC, Alves F, Strub-Wourgaft N, Ribeiro I, E1224 Study Group (2018) Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial. Lancet Infect Dis 18:419\u2013430. https:\/\/doi.org\/10.1016\/S1473-3099(17)30538-8","journal-title":"Lancet Infect Dis"},{"key":"796_CR12","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1056\/NEJMoa1313122","volume":"370","author":"I Molina","year":"2014","unstructured":"Molina I, G\u00f3mez i Prat J, Salvador F, Trevi\u00f1o B, Sulleiro E, Serre N, Pou D, Roure S, Cabezos J, Valerio L, Blanco-Grau A, S\u00e1nchez-Montalv\u00e1 A, Vidal X, Pahissa A (2014) Randomized trial of posaconazole and benznidazole for chronic Chagas\u2019 disease. N Engl J Med 370:1899\u20131908. https:\/\/doi.org\/10.1056\/NEJMoa1313122","journal-title":"N Engl J Med"},{"key":"796_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1128\/AAC.01401-12","volume":"57","author":"MJ Pinazo","year":"2013","unstructured":"Pinazo MJ, Guerrero L, Posada E, Rodr\u00edguez E, Soy D, Gascon J (2013) Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic Chagas disease. Antimicrob Agents Chemother 57:390\u2013395. https:\/\/doi.org\/10.1128\/AAC.01401-12","journal-title":"Antimicrob Agents Chemother"},{"key":"796_CR14","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1086\/656917","volume":"51","author":"Y Jackson","year":"2010","unstructured":"Jackson Y, Alirol E, Getaz L, Wolff H, Combescure C, Chappuis F (2010) Tolerance and safety of nifurtimox in patients with chronic Chagas disease. Clin Infect Dis 51:e69\u2013e75. https:\/\/doi.org\/10.1086\/656917","journal-title":"Clin Infect Dis"},{"key":"796_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40475-019-0170-1","volume":"6","author":"CJ Forsyth","year":"2019","unstructured":"Forsyth CJ, Stigler Granados P, Pacheco GJ, Betancourt JA, Meymandi SK (2019) Current gaps and needs for increasing access to healthcare for people with Chagas disease in the USA. Curr Trop Med Reports 6:13\u201322. https:\/\/doi.org\/10.1007\/s40475-019-0170-1","journal-title":"Curr Trop Med Reports"},{"key":"796_CR16","doi-asserted-by":"publisher","first-page":"e0005770","DOI":"10.1371\/journal.pntd.0005770","volume":"11","author":"MJ Pinazo","year":"2017","unstructured":"Pinazo MJ, Pinto J, Ortiz L, S\u00e1nchez J, Garc\u00eda W, Saravia R, Cortez MR, Moriana S, Grau E, Lozano D, Gascon J, Torrico F (2017) A strategy for scaling up access to comprehensive care in adults with Chagas disease in endemic countries: the Bolivian Chagas Platform. PLoS Negl Trop Dis 11:e0005770. https:\/\/doi.org\/10.1371\/journal.pntd.0005770","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1590\/0037-8682-0433-2016","volume":"50","author":"E Pinheiro","year":"2017","unstructured":"Pinheiro E, Brum-Soares L, Reis R, Cubides JC (2017) Chagas disease: review of needs, neglect, and obstacles to treatment access in Latin America. Rev Soc Bras Med Trop 50:296\u2013300. https:\/\/doi.org\/10.1590\/0037-8682-0433-2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"796_CR18","doi-asserted-by":"publisher","first-page":"e0005148","DOI":"10.1371\/journal.pntd.0005148","volume":"5","author":"A Picado","year":"2017","unstructured":"Picado A, Angheben A, Marchiol A et al (2017) Development of diagnostics for Chagas disease: where should we put our limited resources? PLoS Negl Trop Dis 5:e0005148. https:\/\/doi.org\/10.1371\/journal.pntd.0005148","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR19","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1590\/0074-02760140435","volume":"110","author":"MJ Pinazo","year":"2015","unstructured":"Pinazo MJ, Thomas MC, Bustamante J, Almeida IC, Lopez MC, Gascon J (2015) Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives. Mem Inst Oswaldo Cruz 110:422\u2013432. https:\/\/doi.org\/10.1590\/0074-02760140435","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"796_CR20","unstructured":"Drugs for Neglected Diseases initiative (2019) Carta de Santa Cruz. https:\/\/www.dndial.org\/es\/2018\/comunicacion-e-informacion\/es-noticias-dndi\/carta-de-santa-cruz\/. Accessed 30 Jul 2019"},{"key":"796_CR21","doi-asserted-by":"publisher","first-page":"e1691","DOI":"10.1371\/journal.pntd.0001691","volume":"6","author":"V Jamonneau","year":"2012","unstructured":"Jamonneau V, Ilboudo H, Kabor\u00e9 J, Kaba D, Koffi M, Solano P, Garcia A, Courtin D, Laveissi\u00e8re C, Lingue K, B\u00fcscher P, Bucheton B (2012) Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal. PLoS Negl Trop Dis 6:e1691. https:\/\/doi.org\/10.1371\/journal.pntd.0001691","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR22","doi-asserted-by":"publisher","first-page":"e3349","DOI":"10.1371\/journal.pntd.0003349","volume":"8","author":"D Sudarshi","year":"2014","unstructured":"Sudarshi D, Lawrence S, Pickrell WO, Eligar V, Walters R, Quaderi S, Walker A, Capewell P, Clucas C, Vincent A, Checchi F, MacLeod A, Brown M (2014) Human African Trypanosomiasis presenting at least 29 years after infection\u2014what can this teach us about the pathogenesis and control of this neglected tropical disease? PLoS Negl Trop Dis 8:e3349. https:\/\/doi.org\/10.1371\/journal.pntd.0003349","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR23","doi-asserted-by":"publisher","first-page":"e1004469","DOI":"10.1371\/journal.ppat.1004469","volume":"10","author":"H Ilboudo","year":"2014","unstructured":"Ilboudo H, Bras-Gon\u00e7alves R, Camara M, Flori L, Camara O, Sakande H, Leno M, Petitdidier E, Jamonneau V, Bucheton B (2014) Unravelling human trypanotolerance: IL8 is associated with infection control whereas IL10 and TNF\u03b1 are associated with subsequent disease development. PLoS Pathog 10:e1004469. https:\/\/doi.org\/10.1371\/journal.ppat.1004469","journal-title":"PLoS Pathog"},{"key":"796_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/cid\/ciw505","volume":"63","author":"L Gineau","year":"2016","unstructured":"Gineau L, Courtin D, Camara M, Ilboudo H, Jamonneau V, Dias FC, Tokplonou L, Milet J, Mendon\u00e7a PB, Castelli EC, Camara O, Camara M, Favier B, Rouas-Freiss N, Moreau P, Donadi EA, Bucheton B, Sabbagh A, Garcia A (2016) Human leukocyte antigen-G: a promising prognostic marker of disease progression to improve the control of human African trypanosomiasis. Clin Infect Dis 63:1189\u20131197. https:\/\/doi.org\/10.1093\/cid\/ciw505","journal-title":"Clin Infect Dis"},{"key":"796_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.revmed.2019.05.004","volume":"40","author":"C Morbieu","year":"2019","unstructured":"Morbieu C, Rollin G, Saada N et al (2019) Un tr\u00e8s mauvais voyage. Confusion in a 45-year-old woman. La Rev M\u00e9decine Interne 40:553\u2013556. https:\/\/doi.org\/10.1016\/j.revmed.2019.05.004","journal-title":"La Rev M\u00e9decine Interne"},{"key":"796_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.meegid.2011.04.011","volume":"11","author":"J Kabor\u00e9","year":"2011","unstructured":"Kabor\u00e9 J, MacLeod A, Jamonneau V et al (2011) Population genetic structure of Guinea Trypanosoma brucei gambiense isolates according to host factors. Infect Genet Evol 11:129\u20131135. https:\/\/doi.org\/10.1016\/j.meegid.2011.04.011","journal-title":"Infect Genet Evol"},{"key":"796_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1126\/science.1193032","volume":"329","author":"G Genovese","year":"2010","unstructured":"Genovese G, Friedman DJ, Ross MD et al (2010) Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science (80- ) 329:841\u2013845. https:\/\/doi.org\/10.1126\/science.1193032","journal-title":"Science (80- )"},{"key":"796_CR28","doi-asserted-by":"publisher","first-page":"e25461","DOI":"10.7554\/eLife.25461","volume":"6","author":"A Cooper","year":"2017","unstructured":"Cooper A, Ilboudo H, Alibu VP et al (2017) APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis. Elife 6:e25461. https:\/\/doi.org\/10.7554\/eLife.25461","journal-title":"Elife"},{"key":"796_CR29","doi-asserted-by":"publisher","first-page":"e0006300","DOI":"10.1371\/journal.pntd.0006300","volume":"12","author":"MP Kimuda","year":"2018","unstructured":"Kimuda MP, Noyes H, Mulindwa J, Enyaru J, Alibu VP, Sidibe I, Mumba Ngoyi D, Hertz-Fowler C, MacLeod A, Tastan Bishop \u00d6, Matovu E, TrypanoGEN Research Group as members of The H3Africa Consortium (2018) No evidence for association between APOL1 kidney disease risk alleles and human African trypanosomiasis in two Ugandan populations. PLoS Negl Trop Dis 12:e0006300. https:\/\/doi.org\/10.1371\/journal.pntd.0006300","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR30","doi-asserted-by":"publisher","first-page":"e0005979","DOI":"10.1371\/journal.pntd.0005979","volume":"11","author":"E Ofon","year":"2017","unstructured":"Ofon E, Noyes H, Mulindwa J, Ilboudo H, Simuunza M, Ebo'o V, Njiokou F, Koffi M, Bucheton B, Fogue P, Hertz-Fowler C, MacLeod A, Simo G, TrypanoGEN Research Group, as members of The H3Africa Consortium (2017) A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations. PLoS Negl Trop Dis 11:e0005979. https:\/\/doi.org\/10.1371\/journal.pntd.0005979","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR31","doi-asserted-by":"publisher","first-page":"e0007283","DOI":"10.1371\/journal.pntd.0007283","volume":"13","author":"E Ofon","year":"2019","unstructured":"Ofon E, Noyes H, Ebo\u2019o Eyanga V et al (2019) Association between IL1 gene polymorphism and human African trypanosomiasis in populations of sleeping sickness foci of southern Cameroon. PLoS Negl Trop Dis 13:e0007283. https:\/\/doi.org\/10.1371\/journal.pntd.0007283","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR32","doi-asserted-by":"publisher","first-page":"e0005992","DOI":"10.1371\/journal.pntd.0005992","volume":"11","author":"B Ahouty","year":"2017","unstructured":"Ahouty B, Koffi M, Ilboudo H, Simo G, Matovu E, Mulindwa J, Hertz-Fowler C, Bucheton B, Sidib\u00e9 I, Jamonneau V, MacLeod A, Noyes H, N'Guetta SP, TrypanoGEN Research Group as members of The H3Africa Consortium (2017) Candidate genes-based investigation of susceptibility to human African trypanosomiasis in C\u00f4te d\u2019Ivoire. PLoS Negl Trop Dis 11:e0005992. https:\/\/doi.org\/10.1371\/journal.pntd.0005992","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR33","unstructured":"Ahouty B, Koffi M, Courtin D, et al (1029) HLA-G 3\u2019UTR 14-bp insertion is associated with a decreased risk of developing human African trypanosomiasis in the C\u00f4te d\u2019Ivoire population. Open J Genet In press"},{"key":"796_CR34","doi-asserted-by":"publisher","first-page":"e0005833","DOI":"10.1371\/journal.pntd.0005833","volume":"11","author":"JW Kabor\u00e9","year":"2017","unstructured":"Kabor\u00e9 JW, Ilboudo H, Noyes H, Camara O, Kabor\u00e9 J, Camara M, Koffi M, Lejon V, Jamonneau V, MacLeod A, Hertz-Fowler C, Belem AMG, Matovu E, Bucheton B, Sidibe I, TrypanoGEN Research Group as members of The H3Africa Consortium (2017) Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea. PLoS Negl Trop Dis 11:e0005833. https:\/\/doi.org\/10.1371\/journal.pntd.0005833","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR35","doi-asserted-by":"publisher","first-page":"e17716","DOI":"10.7554\/eLife.17716","volume":"5","author":"P Capewell","year":"2016","unstructured":"Capewell P, Cren-Travaill\u00e9 C, Marchesi F et al (2016) The skin is a significant but overlooked anatomical reservoir for vector-borne African trypanosomes. Elife 5:e17716. https:\/\/doi.org\/10.7554\/eLife.17716","journal-title":"Elife"},{"key":"796_CR36","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1186\/s13071-015-1131-8","volume":"8","author":"KS Rock","year":"2015","unstructured":"Rock KS, Torr SJ, Lumbala C, Keeling MJ (2015) Quantitative evaluation of the strategy to eliminate human African trypanosomiasis in the Democratic Republic of Congo. Parasit Vectors 8:532. https:\/\/doi.org\/10.1186\/s13071-015-1131-8","journal-title":"Parasit Vectors"},{"key":"796_CR37","first-page":"871","volume":"64","author":"J Fr\u00e9zil","year":"1971","unstructured":"Fr\u00e9zil J (1971) Application du x\u00e9nodiagnostic dans le d\u00e9pistage de la trypanosomiase \u00e0 T. gambiense chez des sujets immunologiquement suspect. Bulletin de la Soci\u00e9t\u00e9 de Pathologie Exotique. Bull Soc Pathol Exot Filiales 64:871\u2013878","journal-title":"Bull Soc Pathol Exot Filiales"},{"key":"796_CR38","first-page":"203","volume":"74","author":"H Bruneel","year":"1994","unstructured":"Bruneel H, Van den Eeckhout A, Molisho D et al (1994) Contr\u00f4le de la trypanosomiase a T.b. gambiense. Evaluation d\u2019une strat\u00e9gie bas\u00e9e sur le traitement des suspects s\u00e9rologiques par une dose unique de diminazene. Ann Soc Belg Med Trop (1920) 74:203\u2013215","journal-title":"Ann Soc Belg Med Trop (1920)"},{"key":"796_CR39","first-page":"53","volume":"39","author":"J-L Fr\u00e9zil","year":"1979","unstructured":"Fr\u00e9zil J-L, Coulm J, Alary J-C (1979) Evolution apr\u00e8s traitement des suspects immunologiques de trypanosomiase non confirm\u00e9s parasitologiquement. M\u00e9decine Trop 39:53\u201356","journal-title":"M\u00e9decine Trop"},{"key":"796_CR40","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.4049\/jimmunol.166.5.3416","volume":"166","author":"S Buates","year":"2001","unstructured":"Buates S, Matlashewski G (2001) General suppression of macrophage gene expression during Leishmania donovani infection. J Immunol 166:3416\u20133422. https:\/\/doi.org\/10.4049\/jimmunol.166.5.3416","journal-title":"J Immunol"},{"key":"796_CR41","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0001-706X(02)00238-3","volume":"85","author":"KP Chang","year":"2003","unstructured":"Chang KP, Reed SG, McGwire BS, Soong L (2003) Leishmania model for microbial virulence: the relevance of parasite multiplication and pathoantigenicity. Acta Trop 85:375\u2013390. https:\/\/doi.org\/10.1016\/S0001-706X(02)00238-3","journal-title":"Acta Trop"},{"key":"796_CR42","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M (2018) Leishmaniasis. Lancet 392:951\u2013970. https:\/\/doi.org\/10.1016\/S0140-6736(18)31204-2","journal-title":"Lancet"},{"key":"796_CR43","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/cid\/ciu102","volume":"58","author":"OP Singh","year":"2014","unstructured":"Singh OP, Hasker E, Sacks D, Boelaert M, Sundar S (2014) Asymptomatic leishmania infection: a new challenge for leishmania control. Clin Infect Dis 58:1424\u20131429. https:\/\/doi.org\/10.1093\/cid\/ciu102","journal-title":"Clin Infect Dis"},{"key":"796_CR44","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1179\/136485907x229121","volume":"101","author":"P Marty","year":"2007","unstructured":"Marty P, Izri A, Ozon C, Haas P, Rosenthal E, del Giudice P, Godenir J, Coulibaly E, Gari-Toussaint M, Delaunay P, Ferrua B, Haas H, Pratlong F, le Fichoux Y (2007) A century of leishmaniasis in Alpes-Maritimes, France. Ann Trop Med Parasitol 101:563\u2013574. https:\/\/doi.org\/10.1179\/136485907x229121","journal-title":"Ann Trop Med Parasitol"},{"key":"796_CR45","doi-asserted-by":"publisher","unstructured":"Ibarra-Meneses AV, Carrillo E, Nieto J et al (2019) Prevalence of asymptomatic Leishmania infection and associated risk factors, after an outbreak in the south-western Madrid region, Spain, 2015. Euro Surveill 24. https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.22.1800379","DOI":"10.2807\/1560-7917.ES.2019.24.22.1800379"},{"key":"796_CR46","doi-asserted-by":"publisher","first-page":"345","DOI":"10.4269\/ajtmh.2009.80.345","volume":"80","author":"M Rai","year":"2009","unstructured":"Rai M, Sundar S, Gidwani K, Kumar R (2009) Longitudinal seroepidemiologic study of visceral leishmaniasis in hyperendemic regions of Bihar, India. Am J Trop Med Hyg 80:345\u2013346. https:\/\/doi.org\/10.4269\/ajtmh.2009.80.345","journal-title":"Am J Trop Med Hyg"},{"key":"796_CR47","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.trstmh.2011.08.005","volume":"105","author":"VNR Das","year":"2011","unstructured":"Das VNR, Siddiqui NA, Verma RB, Topno RK, Singh D, Das S, Ranjan A, Pandey K, Kumar N, Das P (2011) Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans R Soc Trop Med Hyg 105:661\u2013666. https:\/\/doi.org\/10.1016\/j.trstmh.2011.08.005","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"796_CR48","doi-asserted-by":"publisher","first-page":"e0007216","DOI":"10.1371\/journal.pntd.0007216","volume":"13","author":"J Chakravarty","year":"2019","unstructured":"Chakravarty J, Hasker E, Kansal S, Singh OP, Malaviya P, Singh AK, Chourasia A, Singh T, Sudarshan M, Singh AP, Singh B, Singh RP, Ostyn B, Fakiola M, Picado A, Menten J, Blackwell JM, Wilson ME, Sacks D, Boelaert M, Sundar S (2019) Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: a cohort study. PLoS Negl Trop Dis 13:e0007216. https:\/\/doi.org\/10.1371\/journal.pntd.0007216","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR49","doi-asserted-by":"publisher","first-page":"334","DOI":"10.4269\/ajtmh.2002.66.334","volume":"66","author":"CHN Costa","year":"2002","unstructured":"Costa CHN, Stewart JM, Gomes RBB, Garcez LM, Ramos PK, Bozza M, Satoskar A, Dissanayake S, Santos RS, Silva MR, Shaw JJ, David JR, Maguire JH (2002) Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg 66:334\u2013337. https:\/\/doi.org\/10.4269\/ajtmh.2002.66.334","journal-title":"Am J Trop Med Hyg"},{"key":"796_CR50","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/trstmh\/tru146","volume":"108","author":"S Das","year":"2014","unstructured":"Das S, Matlashewski G, Bhunia GS et al (2014) Asymptomatic Leishmania infections in northern India: a threat for the elimination programme? Trans R Soc Trop Med Hyg 108:679\u2013684. https:\/\/doi.org\/10.1093\/trstmh\/tru146","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"796_CR51","doi-asserted-by":"publisher","first-page":"e2053","DOI":"10.1371\/journal.pntd.0002053","volume":"7","author":"E Hasker","year":"2013","unstructured":"Hasker E, Kansal S, Malaviya P, Gidwani K, Picado A, Singh RP, Chourasia A, Singh AK, Shankar R, Menten J, Wilson ME, Boelaert M, Sundar S (2013) Latent infection with Leishmania donovani in Highly Endemic Villages in Bihar, India. PLoS Negl Trop Dis 7:e2053. https:\/\/doi.org\/10.1371\/journal.pntd.0002053","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR52","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1179\/000349809x12554106963555","volume":"103","author":"A Hailu","year":"2009","unstructured":"Hailu A, Gramiccia M, Kager PA (2009) Visceral leishmaniasis in Aba-Roba, south\u2013western Ethiopia: prevalence and incidence of active and subclinical infections. Ann Trop Med Parasitol 103:659\u2013670. https:\/\/doi.org\/10.1179\/000349809x12554106963555","journal-title":"Ann Trop Med Parasitol"},{"key":"796_CR53","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1046\/j.1365-2249.1999.00844.x","volume":"116","author":"A Sassi","year":"1999","unstructured":"Sassi A, Louzir H, Ben SA et al (1999) Leishmanin skin test lymphoproliferative responses and cytokine production after symptomatic or asymptomatic Leishmania major infection in Tunisia. Clin Exp Immunol 116:127\u2013132. https:\/\/doi.org\/10.1046\/j.1365-2249.1999.00844.x","journal-title":"Clin Exp Immunol"},{"key":"796_CR54","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fcimb.2017.00200","volume":"7","author":"AV Ibarra-Meneses","year":"2017","unstructured":"Ibarra-Meneses AV, Ghosh P, Hossain F et al (2017) IFN-\u03b3, IL-2, IP-10, and MIG as biomarkers of exposure to Leishmania spp., and of cure in human visceral Leishmaniasis. Front Cell Infect Microbiol 7:200. https:\/\/doi.org\/10.3389\/fcimb.2017.00200","journal-title":"Front Cell Infect Microbiol"},{"key":"796_CR55","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.actatropica.2011.05.012","volume":"119","author":"G Michel","year":"2011","unstructured":"Michel G, Pomares C, Ferrua B, Marty P (2011) Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop 119:69\u201375. https:\/\/doi.org\/10.1016\/j.actatropica.2011.05.012","journal-title":"Acta Trop"},{"key":"796_CR56","doi-asserted-by":"publisher","first-page":"e1405","DOI":"10.1371\/journal.pntd.0001405","volume":"5","author":"A Stauch","year":"2011","unstructured":"Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Duerr HP (2011) Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis 5:e1405. https:\/\/doi.org\/10.1371\/journal.pntd.0001405","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1365-3156.2010.02517.x","volume":"15","author":"P Das","year":"2010","unstructured":"Das P, Samuels S, Desjeux P et al (2010) Annual incidence of visceral leishmaniasis in an endemic area of Bihar, India. Tropical Med Int Health 15:4\u201311. https:\/\/doi.org\/10.1111\/j.1365-3156.2010.02517.x","journal-title":"Tropical Med Int Health"},{"key":"796_CR58","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1086\/315795","volume":"182","author":"CHN Costa","year":"2000","unstructured":"Costa CHN, Gomes RBB, Silva MRB, Garcez LM, Ramos PK, Santos RS, Shaw JJ, David JR, Maguire JH (2000) Competence of the human host as a reservoir for Leishmania chagasi. J Infect Dis 182:997\u20131000. https:\/\/doi.org\/10.1086\/315795","journal-title":"J Infect Dis"},{"key":"796_CR59","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1128\/JCM.00921-06","volume":"44","author":"JA Garc\u00eda-Garc\u00eda","year":"2006","unstructured":"Garc\u00eda-Garc\u00eda JA, Mart\u00edn-S\u00e1nchez J, G\u00e1llego M, Rivero-Rom\u00e1n A, Camacho A, Riera C, Morillas-M\u00e1rquez F, Vergara S, Mac\u00edas J, Pineda JA (2006) Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients. J Clin Microbiol 44:4455\u20134458. https:\/\/doi.org\/10.1128\/JCM.00921-06","journal-title":"J Clin Microbiol"},{"key":"796_CR60","doi-asserted-by":"publisher","first-page":"e0004179","DOI":"10.1371\/journal.pntd.0004179","volume":"9","author":"E Carrillo","year":"2015","unstructured":"Carrillo E, Carrasco-Ant\u00f3n N, L\u00f3pez-Medrano F, Salto E, Fern\u00e1ndez L, San Mart\u00edn JV, Alvar J, Aguado JM, Moreno J (2015) Cytokine release assays as tests for exposure to Leishmania, and for confirming cure from leishmaniasis, in solid organ transplant recipients. PLoS Negl Trop Dis 9:e0004179. https:\/\/doi.org\/10.1371\/journal.pntd.0004179","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR61","doi-asserted-by":"publisher","first-page":"e0007461","DOI":"10.1371\/journal.pntd.0007461","volume":"13","author":"L Botana","year":"2019","unstructured":"Botana L, Ibarra-Meneses AV, S\u00e1nchez C, Castro A, San Martin JV, Molina L, Ruiz-Giardin JM, Carrillo E, Moreno J (2019) Asymptomatic immune responders to Leishmania among HIV positive patients. PLoS Negl Trop Dis 13:e0007461. https:\/\/doi.org\/10.1371\/journal.pntd.0007461","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR62","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00002030-199402000-00024","volume":"8","author":"R Molina","year":"1994","unstructured":"Molina R, Cafiavate C, Cercenado E et al (1994) Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus. AIDS 8:277\u2013279. https:\/\/doi.org\/10.1097\/00002030-199402000-00024","journal-title":"AIDS"},{"key":"796_CR63","doi-asserted-by":"publisher","first-page":"5109","DOI":"10.1016\/j.actatropica.2010.01.014","volume":"120","author":"PE Simonsen","year":"2011","unstructured":"Simonsen PE, Onapa AW, Asio SM (2011) Mansonella perstans filariasis in Africa. Acta Trop 120:5109\u20135120. https:\/\/doi.org\/10.1016\/j.actatropica.2010.01.014","journal-title":"Acta Trop"},{"key":"796_CR64","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/infdis\/163.6.1318","volume":"163","author":"AD Klion","year":"1991","unstructured":"Klion AD, Massougbodji A, Sadeler BC, Ottesen EA, Nutman TB (1991) Loiasis in endemic and nonendemic populations: immunologically mediated differences in clinical presentation. J Infect Dis 163:1318\u20131325. https:\/\/doi.org\/10.1093\/infdis\/163.6.1318","journal-title":"J Infect Dis"},{"key":"796_CR65","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1469-0691.2011.03586.x","volume":"17","author":"A Hoerauf","year":"2011","unstructured":"Hoerauf A, Pfarr K, Mand S, Debrah AY, Specht S (2011) Filariasis in Africa-treatment challenges and prospects. Clin Microbiol Infect 17:977\u2013985. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03586.x","journal-title":"Clin Microbiol Infect"},{"key":"796_CR66","volume-title":"Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis","author":"World Health Organization","year":"2017","unstructured":"World Health Organization (2017) Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis"},{"key":"796_CR67","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1471-4922(01)02173-0","volume":"18","author":"A Hoerauf","year":"2002","unstructured":"Hoerauf A, Brattig N (2002) Resistance and susceptibility in human onchocerciasis - beyond Th1 vs Th2. Trends Parasitol 18:25\u201331. https:\/\/doi.org\/10.1016\/S1471-4922(01)02173-0","journal-title":"Trends Parasitol"},{"key":"796_CR68","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jaci.2016.07.007","volume":"138","author":"RM Maizels","year":"2016","unstructured":"Maizels RM, McSorley HJ (2016) Regulation of the host immune system by helminth parasites. J Allergy Clin Immunol 138:666\u2013675. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.007","journal-title":"J Allergy Clin Immunol"},{"key":"796_CR69","doi-asserted-by":"publisher","first-page":"e3414","DOI":"10.1371\/journal.pntd.0003414","volume":"9","author":"G Katawa","year":"2015","unstructured":"Katawa G, Layland LE, Debrah AY, von Horn C, Batsa L, Kwarteng A, Arriens S, W Taylor D, Specht S, Hoerauf A, Adjobimey T (2015) Hyperreactive onchocerciasis is characterized by a combination of Th17-Th2 immune responses and reduced regulatory T cells. PLoS Negl Trop Dis 9:e3414. https:\/\/doi.org\/10.1371\/journal.pntd.0003414","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR70","doi-asserted-by":"publisher","first-page":"e1611","DOI":"10.1371\/journal.pntd.0001611","volume":"6","author":"K Arndts","year":"2012","unstructured":"Arndts K, Deininger S, Specht S, Klarmann U, Mand S, Adjobimey T, Debrah AY, Batsa L, Kwarteng A, Epp C, Taylor M, Adjei O, Layland LE, Hoerauf A (2012) Elevated adaptive immune responses are associated with latent infections of Wuchereria bancrofti. PLoS Negl Trop Dis 6:e1611. https:\/\/doi.org\/10.1371\/journal.pntd.0001611","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR71","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-3024.2005.00792.x","volume":"27","author":"A Hoerauf","year":"2005","unstructured":"Hoerauf A, Satoguina J, Saeftel M, Specht S (2005) Immunomodulation by filarial nematodes. Parasite Immunol 27:417\u2013429. https:\/\/doi.org\/10.1111\/j.1365-3024.2005.00792.x","journal-title":"Parasite Immunol"},{"key":"796_CR72","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/dmrr.2673","volume":"32","author":"A Berbudi","year":"2016","unstructured":"Berbudi A, Ajendra J, Wardani APF, Hoerauf A, H\u00fcbner MP (2016) Parasitic helminths and their beneficial impact on type 1 and type 2 diabetes. Diabetes Metab Res Rev 32:238\u2013250. https:\/\/doi.org\/10.1002\/dmrr.2673","journal-title":"Diabetes Metab Res Rev"},{"key":"796_CR73","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/2049-632X.12080","volume":"69","author":"MP H\u00fcbner","year":"2013","unstructured":"H\u00fcbner MP, Layland LE, Hoerauf A (2013) Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour? Pathog Dis 69:127\u2013141. https:\/\/doi.org\/10.1111\/2049-632X.12080","journal-title":"Pathog Dis"},{"key":"796_CR74","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.4049\/jimmunol.1003778","volume":"186","author":"S Metenou","year":"2011","unstructured":"Metenou S, Dembele B, Konate S, Dolo H, Coulibaly YI, Diallo AA, Soumaoro L, Coulibaly ME, Coulibaly SY, Sanogo D, Doumbia SS, Traor\u00e9 SF, Mahanty S, Klion A, Nutman TB (2011) Filarial infection suppresses malaria-specific multifunctional Th1 and Th17 responses in malaria and filarial coinfections. J Immunol 186:4725\u20134733. https:\/\/doi.org\/10.4049\/jimmunol.1003778","journal-title":"J Immunol"},{"key":"796_CR75","doi-asserted-by":"publisher","first-page":"916","DOI":"10.4049\/jimmunol.0900257","volume":"183","author":"S Metenou","year":"2009","unstructured":"Metenou S, Demb\u00e9l\u00e9 B, Konate S, Dolo H, Coulibaly SY, Coulibaly YI, Diallo AA, Soumaoro L, Coulibaly ME, Sanogo D, Doumbia SS, Wagner M, Traor\u00e9 SF, Klion A, Mahanty S, Nutman TB (2009) Patent filarial infection modulates malaria-specific type 1 cytokine responses in an IL-10-dependent manner in a filaria\/malaria-coinfected population. J Immunol 183:916\u2013924. https:\/\/doi.org\/10.4049\/jimmunol.0900257","journal-title":"J Immunol"},{"key":"796_CR76","doi-asserted-by":"publisher","first-page":"e1890","DOI":"10.1371\/journal.pntd.0001890","volume":"6","author":"H Dolo","year":"2012","unstructured":"Dolo H, Coulibaly YI, Dembele B et al (2012) Filariasis attenuates anemia and proinflammatory responses associated with clinical malaria: a matched prospective study in children and young adults. PLoS Negl Trop Dis 6:e1890. https:\/\/doi.org\/10.1371\/journal.pntd.0001890","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR77","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.it.2016.07.005","volume":"37","author":"S Babu","year":"2016","unstructured":"Babu S, Nutman TB (2016) Helminth-tuberculosis co-infection: an immunologic perspective. Trends Immunol 37:597\u2013607. https:\/\/doi.org\/10.1016\/j.it.2016.07.005","journal-title":"Trends Immunol"},{"key":"796_CR78","doi-asserted-by":"publisher","first-page":"e94603","DOI":"10.1371\/journal.pone.0094603","volume":"9","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Kolappan C, Subramani R, Gopi PG, Chandrasekaran V, Fay MP, Babu S, Kumaraswami V, Nutman TB (2014) Incidence of active pulmonary tuberculosis in patients with coincident filarial and\/or intestinal helminth infections followed longitudinally in South India. PLoS One 9:e94603. https:\/\/doi.org\/10.1371\/journal.pone.0094603","journal-title":"PLoS One"},{"key":"796_CR79","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/S0140-6736(16)31252-1","volume":"388","author":"I Kroidl","year":"2016","unstructured":"Kroidl I, Saathoff E, Maganga L et al (2016) Effect of Wuchereria bancrofti infection on HIV incidence in southwest Tanzania: a prospective cohort study. Lancet 388:1912\u20131920. https:\/\/doi.org\/10.1016\/S0140-6736(16)31252-1","journal-title":"Lancet"},{"key":"796_CR80","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1126\/science.1256942","volume":"345","author":"LC Osborne","year":"2014","unstructured":"Osborne LC, Monticelli LA, Nice TJ et al (2014) Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation. Science (80- ) 345:578\u2013582. https:\/\/doi.org\/10.1126\/science.1256942","journal-title":"Science (80- )"},{"key":"796_CR81","doi-asserted-by":"publisher","first-page":"e0003622","DOI":"10.1371\/journal.pntd.0003622","volume":"9","author":"KR Talaat","year":"2015","unstructured":"Talaat KR, Babu S, Menon P, Kumarasamy N, Sharma J, Arumugam J, Dhakshinamurthy K, Srinivasan R, Poongulali S, Gu W, Fay MP, Swaminathan S, Nutman TB (2015) Treatment of W. bancrofti (Wb) in HIV\/Wb coinfections in South India. PLoS Negl Trop Dis 9:e0003622. https:\/\/doi.org\/10.1371\/journal.pntd.0003622","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR82","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1086\/515661","volume":"178","author":"P Cooper","year":"1998","unstructured":"Cooper P, Espinel I, Paredes W, Guderian RH, Nutman TB (1998) Impaired tetanus-specific cellular and humoral responses following tetanus vaccination in human Onchocerciasis: a possible role for interleukin-10. J Infect Dis 178:1133\u20131138. https:\/\/doi.org\/10.1086\/515661","journal-title":"J Infect Dis"},{"key":"796_CR83","unstructured":"World Health Organization (2018) WHO technical consultation on research requirements to support policy recommendations on highly sensitive point-of-care diagnostics for P. falciparum malaria. In: World Malar. Rep. www.who.int\/malaria. Accessed 12 Sept 2019"},{"key":"796_CR84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12916-018-1243-z","volume":"17","author":"A Bj\u00f6rkman","year":"2019","unstructured":"Bj\u00f6rkman A, Shakely D, Ali AS, Morris U, Mkali H, Abbas AK, al-Mafazy AW, Haji KA, Mcha J, Omar R, Cook J, Elfving K, Petzold M, Sachs MC, Aydin-Schmidt B, Drakeley C, Msellem M, M\u00e5rtensson A (2019) From high to low malaria transmission in Zanzibar - challenges and opportunities to achieve elimination. BMC Med 17:14. https:\/\/doi.org\/10.1186\/s12916-018-1243-z","journal-title":"BMC Med"},{"key":"796_CR85","doi-asserted-by":"publisher","first-page":"e00626","DOI":"10.7554\/eLife.00626","volume":"2","author":"TS Churcher","year":"2013","unstructured":"Churcher TS, Bousema T, Walker M, Drakeley C, Schneider P, Ou\u00e9draogo AL, Bas\u00e1\u00f1ez MG (2013) Predicting mosquito infection from Plasmodium falciparum gametocyte density and estimating the reservoir of infection. Elife 2:e00626. https:\/\/doi.org\/10.7554\/eLife.00626","journal-title":"Elife"},{"key":"796_CR86","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrmicro3364","volume":"12","author":"T Bousema","year":"2014","unstructured":"Bousema T, Okell L, Felger I, Drakeley C (2014) Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat Rev Microbiol 12:833\u2013840. https:\/\/doi.org\/10.1038\/nrmicro3364","journal-title":"Nat Rev Microbiol"},{"key":"796_CR87","doi-asserted-by":"publisher","first-page":"e0004443","DOI":"10.1371\/journal.pntd.0004443","volume":"10","author":"S Britton","year":"2016","unstructured":"Britton S, Cheng Q, Grigg MJ et al (2016) Sensitive detection of Plasmodium vivax using a high-throughput, colourimetric loop mediated isothermal amplification (HtLAMP) platform: a potential novel tool for malaria elimination. PLoS Negl Trop Dis 10:e0004443. https:\/\/doi.org\/10.1371\/journal.pntd.0004443","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR88","first-page":"321","volume":"11","author":"G Hassanpour","year":"2017","unstructured":"Hassanpour G, Mohebali M, Zeraati H et al (2017) Asymptomatic malaria and its challenges in the malaria elimination program in Iran: a systematic review. J Arthropod Borne Dis 11:321\u2013330","journal-title":"J Arthropod Borne Dis"},{"key":"796_CR89","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1086\/655688","volume":"51","author":"V d\u2019Acremont","year":"2010","unstructured":"d\u2019Acremont V, Malila A, Swai N et al (2010) Withholding antimalarials in febrile children who have a negative result for a rapid diagnostic test. Clin Infect Dis 51:506\u2013511. https:\/\/doi.org\/10.1086\/655688","journal-title":"Clin Infect Dis"},{"key":"796_CR90","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/cid\/cir901","volume":"54","author":"N Senn","year":"2012","unstructured":"Senn N, Rarau P, Manong D, Salib M, Siba P, Robinson LJ, Reeder J, Rogerson S, Mueller I, Genton B (2012) Rapid diagnostic test-based management of malaria: an effectiveness study in Papua New Guinean infants with plasmodium falciparum and plasmodium vivax malaria. Clin Infect Dis 54:644\u2013651. https:\/\/doi.org\/10.1093\/cid\/cir901","journal-title":"Clin Infect Dis"},{"key":"796_CR91","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S1473-3099(18)30411-0","volume":"18","author":"NE Hofmann","year":"2018","unstructured":"Hofmann NE, Gruenberg M, Nate E, Ura A, Rodriguez-Rodriguez D, Salib M, Mueller I, Smith TA, Laman M, Robinson LJ, Felger I (2018) Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study. Lancet Infect Dis 18:1108\u20131116. https:\/\/doi.org\/10.1016\/S1473-3099(18)30411-0","journal-title":"Lancet Infect Dis"},{"key":"796_CR92","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1086\/644781","volume":"200","author":"LC Okell","year":"2009","unstructured":"Okell LC, Ghani AC, Lyons E, Drakeley CJ (2009) Submicroscopic infection in Plasmodium falciparum \u2013endemic populations: a systematic review and meta-analysis. J Infect Dis 200:1509\u20131517. https:\/\/doi.org\/10.1086\/644781","journal-title":"J Infect Dis"},{"key":"796_CR93","doi-asserted-by":"publisher","unstructured":"Okell LC, Bousema T, Griffin JT et al (2012) Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun 3. https:\/\/doi.org\/10.1038\/ncomms2241","DOI":"10.1038\/ncomms2241"},{"key":"796_CR94","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1473-3099(18)30046-X","volume":"18","author":"TN Nguyen","year":"2018","unstructured":"Nguyen TN, von Seidlein L, Nguyen TV et al (2018) The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study. Lancet Infect Dis 18:565\u2013572. https:\/\/doi.org\/10.1016\/S1473-3099(18)30046-X","journal-title":"Lancet Infect Dis"},{"key":"796_CR95","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13071-018-2787-7","volume":"11","author":"ACG Almeida","year":"2018","unstructured":"Almeida ACG, Kuehn A, Castro AJM, Vitor-Silva S, Figueiredo EFG, Brasil LW, Brito MAM, Sampaio VS, Bassat Q, Felger I, Tadei WP, Monteiro WM, Mueller I, Lacerda MVG (2018) High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon. Parasit Vectors 11:194. https:\/\/doi.org\/10.1186\/s13071-018-2787-7","journal-title":"Parasit Vectors"},{"key":"796_CR96","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4269\/ajtmh.18-0399","volume":"100","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi T, Kanyangarara M, Laban NM et al (2019) Characteristics of subpatent malaria in a pre-elimination setting in southern Zambia. Am J Trop Med Hyg 100:280\u2013286. https:\/\/doi.org\/10.4269\/ajtmh.18-0399","journal-title":"Am J Trop Med Hyg"},{"key":"796_CR97","doi-asserted-by":"publisher","first-page":"e3413","DOI":"10.1371\/journal.pntd.0003413","volume":"9","author":"Q Cheng","year":"2015","unstructured":"Cheng Q, Cunningham J, Gatton ML (2015) Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors. PLoS Negl Trop Dis 9:e3413. https:\/\/doi.org\/10.1371\/journal.pntd.0003413","journal-title":"PLoS Negl Trop Dis"},{"key":"796_CR98","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12936-015-0884-z","volume":"14","author":"CM Moreira","year":"2015","unstructured":"Moreira CM, Abo-Shehada M, Price RN, Drakeley CJ (2015) A systematic review of sub-microscopic Plasmodium vivax infection. Malar J 14:360. https:\/\/doi.org\/10.1186\/s12936-015-0884-z","journal-title":"Malar J"},{"key":"796_CR99","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/1475-2875-5-121","volume":"5","author":"RE Coleman","year":"2006","unstructured":"Coleman RE, Sattabongkot J, Promstaporm S et al (2006) Comparison of PCR and microscopy for the detection of asymptomatic malaria in a Plasmodium falciparum\/vivax endemic area in Thailand. Malar J 5:121. https:\/\/doi.org\/10.1186\/1475-2875-5-121","journal-title":"Malar J"},{"key":"796_CR100","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12936-018-2201-0","volume":"17","author":"M Gruenberg","year":"2018","unstructured":"Gruenberg M, Moniz CA, Hofmann NE, Wampfler R, Koepfli C, Mueller I, Monteiro WM, Lacerda M, de Melo GC, Kuehn A, Siqueira AM, Felger I (2018) Plasmodium vivax molecular diagnostics in community surveys: pitfalls and solutions. Malar J 17:55. https:\/\/doi.org\/10.1186\/s12936-018-2201-0","journal-title":"Malar J"},{"key":"796_CR101","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1128\/JCM.01057-14","volume":"52","author":"M Imwong","year":"2014","unstructured":"Imwong M, Hanchana S, Malleret B, R\u00e9nia L, Day NP, Dondorp A, Nosten F, Snounou G, White NJ (2014) High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol 52:3303\u20133309. https:\/\/doi.org\/10.1128\/JCM.01057-14","journal-title":"J Clin Microbiol"},{"key":"796_CR102","doi-asserted-by":"publisher","first-page":"e1001788","DOI":"10.1371\/journal.pmed.1001788","volume":"12","author":"N Hofmann","year":"2015","unstructured":"Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I (2015) Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med 12:e1001788. https:\/\/doi.org\/10.1371\/journal.pmed.1001788","journal-title":"PLoS Med"}],"container-title":["Seminars in Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00796-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00281-020-00796-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00281-020-00796-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:15:13Z","timestamp":1616026513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00281-020-00796-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1007\/s00281-020-00796-y","relation":{},"ISSN":["1863-2297","1863-2300"],"issn-type":[{"value":"1863-2297","type":"print"},{"value":"1863-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"18 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}